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Inhibition of Notch 1 receptor influenced
the differentiation of Lin-CD45RA-dendritic
cell precursors within ovarian carcinoma
microenvironment
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Abstract
Background: Previous evidence suggested that the differentiation of Lin-CD45RA-DC precursors were prior to
plasmcytoid dendritic cells (pDCs) than myeloid dendritic cells (mDCs) within ovarian cancer microenvironment.
However, the mechanism is still unclear. Therefore, we investigated the function of Notch 1 signal pathway in the
differentiation of Lin-CD45RA-DC precursors.
Methods: The CD34+ hematopoietic stem cells were extracted from umbilical cord blood in term parturition, and
Lin-CD45RA-DC precusors were separated and induced mature. Expression of Notch1 receptor and ligands in
Lin-CD45RA-DC precusors was detected by Real-time PCR and was down-regulated by shRNA or γ-secretase
inhibitor (GSI). Flow cytometry was used to analyze the subset of DCs with or without SKOV3 culture supernatants.
IL-12 level was detected by ELISA.
Results: Expression of Notch1 receptors and ligands were detected in Lin-CD45RA-DC precursor cells. The Notch1
mRNA in Lin-CD45RA-DC precursors can be down-regulated by shRNA-Notch1 lentivirus transfection and GSI.
ShRNA mediated Notch 1 knock-down significantly differentiated less plasmcytoid dendritic cells (pDCs), but
generated more myeloid dendritic cells (mDCs), and this would not be influenced by the supernatant of the
ovarian carcinoma cell line. GSI had the same effect in the differentiation of pDC. The secretion of IL-12 significantly
increased after Notch1 knock-down with or without SKOV3 culture supernatants.
Conclusions: Notch1 is an important signaling pathway in the differentiation of Lin-CD45RA-DC precursor cells to
plasmcytoid dendritic cells (pDCs). And this would not be affected by the supernatant of the ovarian carcinoma cell line.
Keywords: Ovarian carcinoma, Dendritic cell(DC), Myeloid dendritic cell (mDC), Plasmacytoid dendritic cell (pDC),
Precursor, Notch1
Background
Ovarian epithelial carcinoma is one of the most common
gynecological malignancies encountered in the clinic. It
has a biological behavior of metastasis initiated at an
early stage and rapidly spread over the peritoneal cavity.
Published literatures revealed that the immune deficiency
in tumor microenvironment plays an important role in
the pathogenesis of ovarian cancer, and also influences the
disease progression, and overall survival rate [1–3]. One
evidence to support the above statement is that the ma-
tured myloid DCs (mDCs, HLA-DR + CD11C + CD123−),
which are considered as the most potent antigen-
presentation cells, infiltrate rarely into the tumor site
in the patients with ovarian carcinoma. Of note,
mDCs play an important role in promoting immune
response, while the plasmcytoid DCs (pDC, HLA-DR +
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It is known that mDC precursors would probably
present as Lin-CD45RA- cells because no specific sur-
face markers such as CD45RA were expressed and
lineage negative. However, each DC subtypes have the
potential ability to differentiate through either myeloid
or lymphoid-lineages and the DC development is quite
flexible rather than their lineage restriction [8, 9]. In our
previous study, we cultured such precursors that gener-
ated from CD34+ human progenitor cells (HPC) with
GM-CSF and TNF-α in the ovarian carcinoma micro-
environment. Then, we observed that the Lin-CD45RA-
DC precursors differentiated into more pDCs than
mDCs, which indicated that it may favor tumor progres-
sion [10]. However, the mechanism is still unclear.
Notch proteins (Notch 1-4) constitute a group of
highly conserved transmembrane receptors that regulate
cell fate decision during the development of many
mammalian cell lineages. A lot of studies have provided
much data on the critically important role of the Notch
pathway in the differentiation of myeloid cells. Recent
studies also confirmed the expression of Notch protein
in antigen presentation cells and matured DC [11]. More
and more papers concluded that Notch pathway is
associated with DC differentiation. But the conclusions
were controversial [12]. Cheng et al. described that the
differentiation of DC in Notch-1 anti-sense mice was
significantly down-regulated that only half of the normal
level of Notch-1were expressed in HPC [13]. Yet, Radtke
et al. found that in Notch-1 conditional knockout mice,
the thymic DCs, conventional DCs, and Langerhans cells
were in normal level [14].
Based on our previous research works, the current
study is aimed to address the expression of Notch1 in
Lin-CD45RA-DC precursors, and then to illustrate the
relationship between Notch1 and differentiation of the
precursors in vitro.
Methods
Ovarian carcinoma cell line culture and collection of
supernatants
An epithelial ovarian carcinoma cell line SKOV3 was pur-
chased from American Type Culture Collection. SKOV3
was cultured in McCOY'5A (Gibco BRL, USA) with 15 %
FBS and passaged when confluent with 0.25 % trypsin.
When cells grew to about 80 % of bottle plat, the medium
was changed by RPMI 1640 supplemented with 15 % FBS
for 36 h. The supernatants were collected for future use.
Isolation and enlargement of Lin-CD45RA-DC precursors
Normal human cord blood was collected immediately
from the full term deliveries, according to the Institution
Guideline. Informed consents were obtained from all
volunteers. CD34+ HPCs were isolated from cord blood
by magnetic cell separation (MACS, Miltenyi Biotec,
Germany) with the use of anti-CD34 −mAb-conjugated
immunomagnetic beads (Miltenyi Biotec, Germany) ac-
cording to the manufacturer’s instructions. More than
95 % of the isolated cells expressed CD34 when analyzed
by flow cytometry (data not shown). Enriched CD34+
HPC (with initial density of 5 × 105/ml) were cultured in
RPMI 1640 supplemented with 15 % FBS, penicillin (100
U/ml), and streptomycin (100 mg/ml). Cells were main-
tained at 37 °C in a 5 % CO2 humidified atmosphere for 7
days in the presence of recombined human cytokines (R&D
system, USA) FLT-3L (50 ng/ml) and SCF (50 ng/ml), could
only expand but not influence the differentiation of the pre-
cursors[15, 16], for enlargement. Half the culture medium
and cytokines were renewed every 3 days. Expanded pro-
genitor cells were then collected for sorting DC precursors.
In brief, cells were incubated with (FITC)-conjugated
Lineage cocktail 1 (Lin 1, BD Biosource, USA) for 10 min
in 4 °C. After washed with buffer solution and incubated
with anti-FITC microbeads (MiltenyiBiotec, Germany) for
20 min in 4 °C, cells were isolated by automatic MACS. Lin
1 contains monoclonal antibody (mAb) clones against CD3
(T cells), CD14 (monocytes/macrophages), CD16 (natural
killer cells), CD19 (B cells), and CD20 (B cells), CD56 (nat-
ural killer cells). After isolation all these cells were removed.
Then by using CD45RA microbeads (MiltenyiBiotec,
Germany), Lin-CD45RA- cells were obtained. More than
95 % of these isolated cells were Lin-CD45RA- when ana-
lyzed by flow cytometry.
Quantitative real-time PCR
RNA expression was measured by using a Quantitative
Real-Time PCR (qRT-PCR ) assay with the SYBR Green I
dye. The housekeeping gene, GAPDH, was used as an in-
ternal control. After cells were collected, total RNA was
extracted from Lin- CD45RA- cells by using TRIzol reagent
(TaKaRa, Dalian, China). cDNA was synthesized by a
Table 1 List of gene-specific primer sequences used for quantitative real-time PCR




Jagged2 5’ GCTATTTCGAGCTGCAGCTGAG3’ 5’GCGGCAGGTAGAAGGAGTTG 3’
Delta 1 5’CTACACGGGCAGGAACTGCAG3’ 5’CGCCTTCTTGTTGGTGTTCTTG3’
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PrimeScript RT reagent kit (TaKaRa, Dalian, China). The
mRNA-specific primers were designed with the Lasergene
software (DNASTAR, Madison, WI) and span at least one
intron with an average length > 800 bp. PCR experiments
were conducted on an MX3000P real-time PCR thermal
cycler using software version 4.01 (Stratagene, La Jolla,
CA). PCR products were electrophorized on 2 % (w/v)
agarose gels. All qRT-PCR measurements were conducted
in triplicates. The relative mRNA expression was calculated
using the △△Ct method. The sequences of the primers for
real-time PCR are listed in Table 1.
Notch1 shRNA lentivirus transfection
Notch1 shRNA (shRNA-Notch1) and negative con-
trol (shRNA-NC) in pGLVl/U6/GFP lentiviral vectors
(purchased from GenePharma Co,Ltd.) were prepared.
The target sequence for Notch1 shRNA was 5’-GGAGC
ATGTGTAACATCAACA-3’. The shRNA-Notch1 lenti-
viral vectors were constructed according to manufactors
suggestion. The Lin-CD45RA-cells were seeded at 5 × 104
cells/well into 96-well plates at 24-h prior to transfection.
When the cells grew to 60–70 % confluenced, transfection
was carried out by using lentiviral particles (Lin-CD45RA-
DC precursors multiplicity of infection (MOI) = 200),
polybrene (5 μg/ml), and enhanced infection solution
(GeneChem Co., Ltd., Shanghai, China), according to the
manufacturer’s protocol. At 12h post-transfection, virus-
containing medium was replaced with complete medium.
At 24h, 72 and 96h post-transfection, all cells were
observed under fluorescence inverted microscope. The
Fig. 1 Real time PCR analysis of Notch 1, Jagged1, 2 and Delta1 in LIN-CD45RA- DC precursors (mean ± SD, n = 3)
Fig. 2 Both pictures showed Lin-CD45RA- cells, however the left picture 24h after transfection and the right picture 72h after transfection (1 ×
109TU/ml 1:4, ×200)
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NOTCH 1 mRNA expression in different time was de-
tected by RT-PCR.
Treatment by γ-secretase inhibitor(GSI)
DAPT (N-[(3, 5-difluorophenyl) acetyl]-L-alanyl-2-phenyl]
glycine-1,1-dimethylethyl) is a kind of GSI. It was bought from
Sigma (USA). In the culture of Lin-CD45RA-DC precursors,
DAPT was added in the culture system to inhibit the Notch
pathway with initial cell density of 5 × 105/ml, at concentrations
of 2.5 to 20μM. Dimethyl sulfoxide (DMSO) (1:1000 dilutions)
was added to the cell culture system as control. Notch1
mRNA expression was detected by qRT-PCR after cells
were cultured with DAPT or DMSO for 72 h.
Induced maturation of Lin-CD45RA-DC precursors in
different culture condition
After being treated in different conditions, Lin-CD45RA-
DC precursors, shRNA-Notch1 transfected cells and cells
Fig. 3 Real-time PCR showed that Notch1 mRNA level significantly decreased after 72h/96h of lentvirus infection in Lin-CD45RA-DC
precursors. **P < 0.01
Fig. 4 The mRNA relative expression of Notch1 after treated with DAPT for 72h (D1: DAPT 2.5μM; M: DAPT 5μM; D3: DAPT 10μM; D4: DAPT
20μM). With the increased concentration of DAPT, the expression of Notch1 decreased till the concentration increased to 20um. The
concentration of 10μM showed the greatest inhibitory effect
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treated by DAPT were all seeded in 24-well plate separ-
ately by a density of 1-5 × 105/ml in 500 μl RPMI 1640
plus GM-CSF (50 ng/ml) and TNF-α (20 ng/ml) for
another 5 days culture.
Flow cytometry analysis
For three-color immunolabeling, 1 × 105cells were labeled
with mAb mixture of peridinin chlorophyll protein
(PeCy5)-conjugated anti-HLA-DR, APC-conjugated anti-
CD11c and phycoerythrin (PE)-conjugated anti-CD123.
At least 100,000cells were analyzed on a BD FACS Arial
II. All of the above mAbs were bought from BD Biosource,
USA. Analysis of flow cytometry data was ebioscience
performed using Expo32 software.
Detection of IL-12 in DC culture supernatants
Human IL-12 was measured quantitatively in Cell-culture
supernatants using the Human Interleukin 12 ELISA Kit
(BlueGene Biotech CO.LTD) according to the instructions
in the kit.
Statistical analysis
The statistical significance was determined using 2-tailed
unpaired Student’s t-test analysis using Prism5 software
(GraphPad). The data are presented as the mean ± SD
with significant difference as p < 0.05. Asterisks were
used to denote P values as: not significant (ns) = P > 0.05;
*P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001.
Results
Notch1 receptors and ligands were detected by RT-PCR in
Lin-CD45RA- DC precursors
In the Lin-CD45RA- DC precursors developed from
CD34+ cells, we can detect the expression of Notch1 re-
ceptors and their ligands, Jagged 1, Jagged 2, and Delta 1


























Fig. 5 a Flow cytometry analysis showed the differentiation of Lin-CD45RA-DC precursors without SKOV3 culture supernatants (n = 3, mean ± SD,
%). shRNA mediated Notch 1 knock down significantly differentiated more mDCs(p = 0.001), but generated less pDCs (p = 0.007). GSI mediated
Notch 1 knock down significantly differentiated less pDCs (p = 0.015), but had no effect on mDCs (p = 0.45). b Representative flow histograms of
DCs subtypes obtained in different culture conditions using a mAb mixture containing HLA-DR, CD11c, and CD123 mAb. The cells were identified
on the basis of their surface expression of HLA-DR, and then DCs were further analyzed by CD11C and CD123 expression within the HLA-DR+ gate.
mDCs and pDCs were defined as HLA-DR + CD11c + CD123- and HLA-DR + CD11c-CD123 +
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had high expressions, while expressions of Jagged2 and
Delta1 were much lower (Fig. 1).
Notch1 was knocked down by shRNA
The shRNA-Notch1 lentiviral expression vector was
constructed and we used it to transfect the Lin-CD45RA-
DC precursors (MOI = 200). The LIN-CD45RA-DC cells
had fluorescence after 24h lentivirus infection. The fluor-
escence demonstrated high transfection efficiency of over
90 % at 72h (1 × 109TU/ml 1:4) (Fig. 2).
The relative expressions of Notch1 mRNA in the follow-
ing groups of blank group, negative control group and
shRNA-Notch1 group after 72h lentivirus infection were
1.002 ± 0.042, 0.909 ± 0.041 and 0.251 ± 0.049 respectively.
The relative expressions of Notch1 mRNA after 96h
lentivirus infection were 0.913 ± 0.035, 0.737 ± 0.062
and 0.133 ± 0.027 respectively. As compared to the
blank group and negative control group, the ShRNA-
Notch1 lentiviral expression vector significantly down
regulated the expression of Notch1 mRNA in Lin-
CD45RA-DC cells. However, there was no significant dif-
ference between the shRNA-Notch 1 lentiviral groups
after 72h lentivirus infection and after 96h lentivirus
infection (0.251 ± 0.049 vs 0.133 ± 0.027, p = 0.10) (Fig.3).
In the following experiment, we used the cells after 72h
lentivirus infection.
Notch1 was knocked down by GSI
Moreover, we also used DAPT to block the Notch1
signaling. According to the experiment, the expres-
sion of Notch1 mRNA was significantly reduced
after treated with a certain concentration (5μM,
10μM, 20uM) at 72h. As a result, cells treated with
10μM DAPT had significant inhibition on Notch1
expression (Fig. 4).
Notch 1 knockdown influenced the differentiation of
Lin-CD45RA-DC precursors without SKOV3 cultured
supernatants
We used 3-colour flow cytometry to analyze the differ-
entiation of Lin-CD45RA- DC precursors in different
conditions. As a result, after lentivirus transfection of
shRNA-Notch1, when compared with control group,
Lin-CD45RA-DC precursors differentiated into more
A
B
Fig. 6 a Flow cytometry analysis showed the differentiation of Lin-CD45RA-DC precursors within SKOV3 culture supernatants(n = 3, mean ± SD,
%). shRNA mediated Notch 1 knock down significantly differentiated more mDCs(p = 0.036), but generated less pDCs (p = 0.01). GSI mediated
Notch 1 knock down significantly differentiated less pDCs (p = 0.013), but had no effect on mDCs (p = 0.45). b Representative flow histograms of
DCs subtypes obtained in different culture conditions using a mAb mixture containing HLA-DR, CD11c, and CD123 mAb. The cells were identified
on the basis of their surface expression of HLA-DR, and then DCs were further analyzed by CD11C and CD123 expression within the HLA-DR+ gate.
mDCs and pDCs were defined as HLA-DR + CD11c + CD123- and HLA-DR + CD11c-CD123 +
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HLA-DR + CD11c + CD123- mDCs(42.03 ± 0.98 % vs
35.17 ± 0.56 %, p = 0.001) and less HLA-DR +CD11c-
CD123+ pDCs ( 2.76 ± 0.42 % vs 5.03 ± 0.33 %, p = 0.007).
As we showed above, DAPT down regulated the ex-
pression of Notch1 mRNA level. But when compared
with control group, the differentiation of Lin-CD45RA-
DC precursors to mDCs in DAPT group was almost the
same (36.07 ± 6.99 % vs 35.17 ± 0.56 %, p = 0.45). Instead,
significant decrease of pDCs was detected. The propor-
tion of pDCs after GSI treating was 2.1 ± 0.8 %, and in
control group was 5.03 ± 0.33 % (p = 0.015). There were
no significant differences in the differentiation to either
mDC or pDC between the shRNA group and GSI group
(p = 0.22; p = 0.26) (Fig. 5a, Fig. 5b).
Notch 1 knockdown influenced the differentiation of
Lin-CD45RA-DC precursors within SKOV3 cultured
supernatants
We have shown previously that SKOV3 cultured super-
natants decreased the number of mDCs and increased
the number of pDCs during the differential process of
Lin-CD45RA-DC precursors. In order to verify the rela-
tionship of Notch1 signaling and the differentiation of
DC precursors in the ovarian cancer microenvironment,
we added SKOV3 cultured supernatants into different
DC precursor culture system.
When the DC-precursors were treated with SKOV3
supernatants, the differentiation to mDCs could also be
significantly increased by shRNA-Notch1 (29.70 ± 0.21 %
vs 23.57 ± 2.53 %, p = 0.036), but not by DAPT (27.97 ±
2.09 % vs 23.57 ± 2.53%, p = 0.125). However, the differen-
tiation to pDCs could be significantly reduced by both
shRNA and DAPT (6.57 ± 0.61% vs 11.57 ± 1.19 %, p =
0.01; 4.67 ± 1.65 % vs 11.57 ± 1.19 %, p = 0.013. respect-
ively). There were no significant differences in the differ-
entiation to either mDC or pDC between the shRNA
group and GSI group (p = 0.22; p = 0.17) (Fig. 6a, Fig.6b).
IL-12 concentrations in vitro
IL-12 is a DC-derived factor that directs the development
of Th1 immune reaction. The capacity of DCs to produce
bioactive IL-12p70 was detected and compared between
groups treated with and without SKOV3-supernatants.
In the groups without SKOV3-supernatants, after
treated with either shRNA or DAPT, the secretion of IL-
12 significantly increased as compared with the control
group (18.54 ± 1.15 vs 5.72 ± 0.35, p = 0.0002; 18.16 ± 0.78
vs 5.72 ± 0.35, p = 0.0003 respectively) (Fig. 7).
The result is the same in the groups with SKOV3-
supernatants, the secretion of IL-12 after treated with
either shRNA or DAPT significantly increased as com-
pared with the control group (6.89 ± 1.04 vs 3.06 ±
0.11, p = 0.011; 6.19 ± 1.01 vs 3.06 ± 0.11, p = 0.018.
respectively) (Fig. 8).
Discussion
There were three main findings of this study. Firstly,
Notch1 and all the Notch family ligands were expressed
in Lin-CD45RA-DC precursors. Secondly, the differenti-
ation of Lin-CD45RA-DC precursor cells to pDCs can
be reduced after knocking down Notch1 by both shRNA
and DAPT, and this process would not be affected by
the supernatant of the ovarian carcinoma cell line.
Thirdly, the secretion of IL-12 significantly increased
after knocking down Notch1 with or without the super-
natants of SKOV3 cell line.
The previous studies, which explored the close rela-
tionship between Notch family and DCs differentiation,
were controversial. It mainly concentrated on the follow-
ing aspects. On the one hand, it is still not clear whether
Notch1 would be a promotion or inhibition role in the
differentiation of the DCs. Hoshino N et al. reported
that Notch signaling was found to promote peripheral
blood monocyte precursors differentiate to DCs and
Langerhans cells [17]. However, De Smedt et al. found
that inhibition of Notch signaling with γ-secretase in-
hibitor shifted differentiation into non-T cells including
monocyte or dendritic cells [18]. Similar contradictory
data exists in respect to the effect of Notch signaling on
pDCs. Oliver et al. reported that Notch signaling via
Delta-1 promoted differentiation of pDC [19]. In a
different study, stromal cells expressing Delta-1 blocked
pDC development [20]. On the other hand, which differ-
entiation stage the Notch1 signal pathway would take
Fig. 7 IL-12 concentrations in three culture supernatants without
SKOV3 culture supernatants (n = 3, mean ± SD). Both shRNA and GSI
mediated Notch 1 knock down significantly produced more IL-12
compared to control group (p = 0.0002, p = 0.0003, respectively)
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effect is still unknown. Most studies were mainly fo-
cused on CD34+ hematopoietic progenitors and DCs
stage. For instance,Els Waegemans et al. reported that
blocking of Notch1 signaling at the stage of CD34+
hematopoietic progenitors resulted in a complete block
in T-lineage specification and induced monocytic and
plasmacytoid dendritic cells [21]. However, another
study, which repealed that MicroRNA-23b promoted
tolerogenic properties of dendritic cells in vitro through
inhibiting Notch1/NF-jB signalling pathways, was mainly
focus on the mature DC stage [22]. Additionally, the
activation of Notch1 signaling by different ligands was
still controversial. Cheng P et al. found that main Notch
ligands Delta-1 and Jagged-1 had the opposite effect on
DC differentiation. Delta-1 promoted generation of fully
differentiated DCs, whereas Jagged-1 stimulated accu-
mulation of DC precursors but prevented their transi-
tion to terminally differentiated DCs [23].
Notably, our present study was mainly discussing
about the Notch1 expression in the Lin-CD45RA-DC
precursors stage and its function in the transformation
of pDCs. As we know, pDCs play an important part in
the mechnism of immune escape, while mDCs secreted
IL-12 would direct the development of Th1 cells and be
in favor of anti-cancer immunity. In this study, we
observed that the amount of pDCs was decreased but
the level of IL-12 was increased in the supernatants of
SKOV3 cell line after knocking down Notch 1. There-
fore, it would be reasonable to hypothesize that Notch1
signaling inhibition may favor anti-tumor immune and it
might provide a new target for immunotherapy of ovarian
epithelial carcinoma.
Another most important and bewildering problem is
that we observed a significant increase in myeloid differ-
entiation after knock-down of the Notch1 by shRNA,
while no such effect was found in GSI mediated Notch 1
knock-down. As a member of hydrolytic enzyme fam-
ilies, DAPT can hydrolyze Notch binding protein to
block the Notch signal, and is also considered to have
the effect to down regulate the Notch1 expression at the
mRNA level [24]. We speculate that there might be
other influential factors in the differentiation of mDCs.
Therefore, further studies are still needed to confirm the
differentiation mechanism of mDCs.
There are also some limitations in our study. For one
thing, it may be appropriate to check for Delta1 and
Fig. 8 IL-12 concentrations in three culture supernatants within SKOV3 culture supernatants (n = 3, mean ± SD). Both shRNA and GSI mediated
Notch 1 knock down significantly produced more IL-12 compared to control group (p = 0.011, p = 0.018, respectively)
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Jagged1 at the protein level for their activation to con-
firm the Notch 1 pathway in the differentiation of Lin-
CD45RA-dendritic cell precursors. For another, it would
be much better to check the knockdown effects of the
canonical Notch target genes: Myc, p21, and the HES-
family members. However, since CD34+ hematopoietic
stem cells extracted from umbilical cord blood were
relatively few, resulting in fewer Lin-CD45RA-DC precur-
sors, then it is really becoming difficulty to complete the
experiment simultaneously. Yet, it would be performed in
our future experiments.
Conclusion
In conclusion, we identified that Notch1 and Notch1
ligands were expressed in Lin-CD45RA-DC precursors.
Notch1 is an important signaling pathway in the differ-
entiation of Lin-CD45RA-DC precursor cells to plas-
mcytoid dendritic cells (pDCs). And this would not be
affected by the supernatant of the ovarian carcinoma cell
line. These findings might provide a new potential thera-
peutic target to ovarian cancer.
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